Evaluating Quality of Life in Patients With Meniere’s Disease Treated as Migraine
Open Access
- 9 September 2018
- journal article
- research article
- Published by SAGE Publications in Annals of Otology, Rhinology & Laryngology
- Vol. 127 (12) , 877-887
Abstract
To evaluate the change in quality of life (QOL) of patients with Meniere’s disease (MD) after treatment with migraine prophylaxis therapy. Patients with definite MD were given the Meniere’s Disease Outcomes Questionnaire–Retrospective (MDOQ-R) after migraine prophylactic therapy to assess QOL. Changes in physical, emotional, and social parameters affected by MD were calculated, along with a global pre- and posttreatment QOL scores. The MDOQ-R was given to 27 consecutive patients with definite MD. Patients who had at least an 18-month follow-up were included, resulting in 25 questionnaires. The mean change in QOL score was 25 ± 16 (range, –3 to 55), P = .02. Quality of life was improved in 23 (92%) of the respondents in every metric measured, unchanged in 1 (4%), and poorer in 1 (4%) of patients after migraine prophylaxis treatment. Majority of MD patients who had all failed diuretic therapy responded positively to medications used for migraine prophylaxis, as indicated by a significant improvement in QOL. This study may further suggest a correlation between the pathophysiologic basis of disease in MD and vestibular migraine. Patients with MD may be successfully managed with medications intended to treat migraine.Keywords
This publication has 50 references indexed in Scilit:
- Endolymphatic Sac Surgery Versus Intratympanic Gentamicin for the Treatment of Intractable Ménière’s DiseaseOtology & Neurotology, 2013
- Dietary Modification as Adjunct Treatment in Ménière’s DiseaseOtology & Neurotology, 2013
- Preventive treatment in migraine and the new US guidelinesNeuropsychiatric Disease and Treatment, 2013
- Topiramate plus nortriptyline in the preventive treatment of migraine: a controlled study for nonrespondersThe Journal of Headache and Pain, 2011
- Management of migraine in adolescentsNeuropsychiatric Disease and Treatment, 2008
- Auditory Results After Vestibular Nerve Section and Intratympanic Gentamicin for Ménière's DiseaseOtology & Neurotology, 2007
- Migraine Associated VertigoJournal of Clinical Neurology, 2007
- Intratympanic gentamicin for Ménière's disease: effect on quality of life as assessed by Glasgow benefit inventoryThe Journal of Laryngology & Otology, 2006
- Long‐Term Hearing Outcome in Patients Receiving Intratympanic Gentamicin for Ménière's DiseaseThe Laryngoscope, 2003
- Intratympanic Gentamicin for Intractable Meniere's DiseaseThe Laryngoscope, 2003